New HIV combo shows promise in early trial
NCT ID NCT06061536
First seen Feb 12, 2026 · Last updated May 10, 2026 · Updated 14 times
Summary
This study tested a new medicine called Lipovirtide, given together with standard HIV drugs, in 64 adults with HIV who had never been treated before. The goal was to see if the combination could safely lower the amount of virus in the blood to very low levels. Participants received different doses of Lipovirtide along with nucleoside drugs, and their virus levels were checked over several months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tianjin Second People's Hospital
Tianjin, Tianjin Municipality, 300000, China
Conditions
Explore the condition pages connected to this study.